BioRem Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	51	44	49	16	14	14
Market Cap Growth	43.83%	-11.49%	213.55%	15.10%	-2.10%	-33.28%
Enterprise Value	43.26	34.89	47.56	17.59	14.61	15.12
Last Close Price	3.12	2.70	3.05	1.00	0.88	0.90
PE Ratio	11.56	10.38	19.06	7.69	9.58	25.95
PS Ratio	1.14	1.03	1.32	0.62	0.47	0.57
PB Ratio	3.31	2.92	4.63	2.34	3.02	7.09
P/TBV Ratio	3.29	3.37	5.37	2.55	3.42	17.14
P/FCF Ratio	39.97	5.99	14.86	-	10.98	3.76
P/OCF Ratio	27.89	5.70	13.36	32.03	9.44	3.68
EV/Sales Ratio	0.97	0.82	1.27	0.70	0.51	0.62
EV/EBITDA Ratio	6.08	5.01	9.87	5.11	4.88	6.27
EV/EBIT Ratio	6.47	5.38	10.95	5.74	5.53	7.31
EV/FCF Ratio	34.17	4.80	14.36	-	11.77	4.08
Debt / Equity Ratio	0.17	0.18	0.32	0.60	1.02	2.79
Debt / EBITDA Ratio	0.37	0.41	0.74	1.22	1.59	2.35
Debt / FCF Ratio	2.09	0.39	1.07	-	3.82	1.53
Net Debt / Equity Ratio	-0.48	-0.58	-0.16	0.28	0.22	0.61
Net Debt / EBITDA Ratio	-1.03	-1.25	-0.34	0.55	0.33	0.50
Net Debt / FCF Ratio	-5.80	-1.19	-0.50	-30.13	0.78	0.32
Asset Turnover	1.36	1.36	1.42	1.12	1.45	1.19
Inventory Turnover	16.90	13.85	14.38	20.28	22.46	19.76
Quick Ratio	1.55	1.62	1.34	1.18	1.24	1.10
Current Ratio	2.02	1.85	1.63	1.41	1.38	1.22
Return on Equity (ROE)	32.96%	37.70%	35.10%	38.78%	49.75%	16.75%
Return on Assets (ROA)	15.66%	15.91%	12.12%	10.68%	8.96%	6.42%
Return on Invested Capital (ROIC)	37.35%	33.93%	21.00%	20.72%	19.60%	15.23%
Return on Capital Employed (ROCE)	39.05%	42.46%	36.70%	34.05%	38.43%	20.63%
Earnings Yield	9.84%	9.63%	5.25%	13.00%	10.44%	3.85%
FCF Yield	2.50%	16.69%	6.73%	-	9.10%	26.60%
Buyback Yield / Dilution	1.39%	0.40%	-9.40%	2.55%	53.08%	5.32%
Total Shareholder Return	1.39%	0.40%	-9.40%	2.55%	53.08%	5.32%